Real-time enrollment status for this anaplastic thyroid cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:01 AM UTC
| NCT Number | NCT06902376 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Thyroid Cancer |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 2 sites in the US |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Last Updated on CT.gov | November 5, 2025 (Nov 5, 2025) |
As of August 28, 2026: Clinical trial NCT06902376 is currently recruiting participants. This phase1 study for anaplastic thyroid cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by UNC Lineberger Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06902376 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06902376 was last updated Nov 5, 2025 (November 5, 2025). HelloStudys verifies this status automatically.